Feb 22, 2011Accelr8 Announces First European Presentation of Rapid Diagnostic Results for New Drug Resistance Test
DENVER, Colo., February 22, 2011 – Accelr8 Technology Corporation (NYSE Alternext US: AXK) announced that clinical research collaborators at the Denver Health Medical Center received...
Nov 6, 2007Subheadline 1
Body copy of news release
Nov 5, 2007Subheadline 1
Body copy of news release.